Compounds > bucladesine

bucladesine and cyclohexanol

bucladesine has been researched along with cyclohexanol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouaboula, M; Bourrié, B; Calandra, B; Canat, X; Casellas, P; Le Fur, G; Poinot-Chazel, C; Rinaldi-Carmona, M1
Cook, SA; Lichtman, AH; Martin, BR1
Grimaldi, M; Hampson, AJ1
Alberich Jordà, M; Battista, N; Delwel, R; Löwenberg, B; Maccarrone, M; Rayman, N; Tas, M; van Lom, K; Verbakel, SE1

Other Studies

4 other study(ies) available for bucladesine and cyclohexanol

ArticleYear
Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.
    The Biochemical journal, 1995, Dec-01, Volume: 312 ( Pt 2)

    Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adenylate Cyclase Toxin; Analgesics; Animals; Benzoquinones; Bucladesine; Calcium-Calmodulin-Dependent Protein Kinases; Cannabinoids; Cell Line; CHO Cells; Cricetinae; Cyclohexanols; DNA-Binding Proteins; Early Growth Response Protein 1; Enzyme Activation; Enzyme Inhibitors; GTP-Binding Proteins; Humans; Immediate-Early Proteins; Kinetics; Lactams, Macrocyclic; Pertussis Toxin; Piperidines; Pyrazoles; Quinones; Receptors, Cannabinoid; Receptors, Drug; Recombinant Proteins; Rifabutin; Rimonabant; Tetradecanoylphorbol Acetate; Transcription Factors; Transfection; Virulence Factors, Bordetella

1995
Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:2

    Topics: Analgesics; Animals; Bucladesine; Cannabinoids; Caudate Nucleus; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Injections, Intraventricular; Male; Periaqueductal Gray; Pertussis Toxin; Rats; Rats, Sprague-Dawley; Stereoisomerism; Virulence Factors, Bordetella

1996
Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity.
    The European journal of neuroscience, 2001, Volume: 13, Issue:8

    Topics: Animals; Bucladesine; Calcium; Calcium Channels; Cannabinoids; Colforsin; Cyclic AMP; Cyclohexanols; Glutamic Acid; Neurotoxins; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug

2001
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner.
    Blood, 2004, Jul-15, Volume: 104, Issue:2

    Topics: Acute Disease; Arachidonic Acids; Bucladesine; Cannabinoid Receptor Modulators; Cell Differentiation; Cell Movement; Cyclic AMP; Cyclohexanols; Down-Regulation; Endocannabinoids; Glycerides; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Ligands; MAP Kinase Signaling System; Mutagenesis, Site-Directed; Neutrophils; Pertussis Toxin; Receptor, Cannabinoid, CB2; Receptors, Granulocyte Colony-Stimulating Factor

2004